SAA (6F9), mAb, Mouse
| $121.00 | |
| V02002-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $121.00 | |
| V02002-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | 8C7, 6F9 recognize human SAA1, SAA2 and SAA4. |
| Recommended Pairs |
TRFIA (Capture-Detection): MLB2 - ML95 LETIA: MLB2 - ML95 ELISA (Capture-Detection): MLB2 - 8C7 8C7 - 6F9 6F9 - 8C7 |
| Affinity | mAbs 6F9 have high affinity binding to SAA |
| Clone ID | 6F9 |
| Isotype | IgG1 for mAbs 6F9 |
| Subclass | IgG1 |
| Host Species | Mouse |
| Antigen Species | Human |
| Conjugation | Unconjugated | |||||||||||||||||||||||||||||||||||||||
| Production | Cultured in vitro under conditions free from animal-derived components | |||||||||||||||||||||||||||||||||||||||
| Purification | Protein A/G affinity column | |||||||||||||||||||||||||||||||||||||||
| Concentration | ≥ 2mg/ml | |||||||||||||||||||||||||||||||||||||||
| Formulation | 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300. | |||||||||||||||||||||||||||||||||||||||
| Storage | For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. | |||||||||||||||||||||||||||||||||||||||
| Product Stability |
|
|||||||||||||||||||||||||||||||||||||||
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. | |||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||
| Target Background | Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection. |
| Synonyms | Serum amyloid A (SAA) Antibody (6F9), mAb, Mouse |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.